Features

Music and psychedelics go hand-in-hand. Could both have a healing effect?

London-based startup Wavepaths is creating a new kind of music technology explicitly designed for psychedelic therapy.

Insect-based foods, fuels, fertilizers, and antimicrobials will be a part of our future, like it or not.

Microbiome research has huge implications for the very sick. But can startups get healthy people in on the action?

An experimental drug that addresses anhedonia could increase the brain’s capacity to experience pleasure and herald a new era of precision medicine in psychiatry.

Demand from body builders, neonatal intensive care units, and Big Pharma fuels synbio substitutions for the goodness of breast milk.

A growing wave of novel substances for performance enhancement or just getting high hits the streets weekly.

Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.

Corporate America is embracing mindfulness more than ever as the pandemic rages. But what do they mean by “mindfulness,” and does it work?

After 175 years, the medical art with a strange and dark history is getting a lot more precise.

We ask the experts what’s coming in the next 12 months.

What your doormat, body odor, or wandering gaze can tell us that we don’t already know.

Combining these two technologies can make CAR T cell therapy effective, accessible, and affordable for heart disease and cancer.

Here are scientific reasons why you should consider a polar bear swim.

Growing interest in psychedelic therapy reveals two different visions of the future: one of spiritual interconnectedness and one of sober neurochemistry.